News
Featured
Eye on the Cure Podcast – Episode 36: Sue Bramhall
.png)
December 2, 2022. Host Ben Shaberman interviews Sue Bramhall.
Recent News
-
Foundation Podcasts
The Eye on the Cure Podcast from the Foundation Fighting Blindness provides science information, news, and insights from the world of vision and retinal diseases. The podcasts are hosted by Ben Shaberman, vice president, science communications, and often include conversations with guests from the research and vision communities.
-
Eye on the Cure Podcast – Transcripts
Foundation PodcastsThe Eye on the Cure Podcast from the Foundation Fighting Blindness provides science information, news, and insights from the world of vision and retinal diseases. The podcasts are hosted by Ben Shaberman, vice president, science communications, and often include conversations with guests from the research and vision communities.
-
Foundation Insights Forum – November 10, 2022
Insights ForumThe Foundation Fighting Blindness is pleased to provide a recording and full transcript of the Insights Forum, our quarterly conference call providing updates to the inherited retinal disease community. The call took place on November 10, 2022.
-
Eye on the Cure Podcast – Episode 35: Kenji Fujita, MD
Foundation PodcastsNovember 18, 2022. Ben Shaberman talks with Kenji Fujita, MD.
-
Press Releases
Uni-Rare Study will improve clinical understanding of more IRDs and boost development of potential therapies.
-
Eye on the Cure Podcast – Episode 34: LambdaVision
Foundation PodcastsNovember 4, 2022. Ben Shaberman talks with LambdaVision’s Nicole Wagner, PhD, and Jordan Greco, PhD.
-
The Foundation in the News
On World Sight Day 2022, Retina International is presenting data from a report on its study into the Socio-economic Impact of late-stage age-related macular degeneration (AMD) in Bulgaria, Germany, and USA.
-
Eye on the Cure Podcast – Episode 33: Jacque Duncan, MD
Foundation PodcastsOctober 7, 2022. Ben Shaberman talks with Jacque Duncan, MD.
-
Press Releases
Initiatives to increase engagement and awareness around blinding retinal diseases.
-
RD Fund Participates in a €75 Million Series B for SparingVision
The Foundation in the NewsProceeds to fund first, in-human trials of breakthrough gene-agnostic therapy products and advance CRISPR-based genome editing portfolio.
.png)
.png)
%20(1).png)
